About Our Company

At Rejuvenate Bio, we are developing novel therapies to treat aging and age-related diseases through innovative targeted gene therapies. We launched out of George Church's lab at Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering at Harvard University.

Leadership Team

George Church, Ph.D.

Co-Founder and SAB

Daniel Oliver, MBA

CEO, Co-Founder

Noah Davidsohn, Ph.D.

CSO, Co-Founder

Deborah Ascheim, M.D.

Chief Medical Officer